🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

😇 Honored to serve as discussant for #ASCO25 oral upper GI abstracts. A powerhouse session with science featured simultaneously in 2 NEJM papers, 1 The Lancet , and 1 Journal of Clinical Oncology —field-leading science shaping our GI oncology practice ✨. UPMC Hillman Cancer Center

😇 Honored to lead & present topline Ph 2 data for DSP107 +/- Atezolizumab in 3L MSS CRC #ASCO25: 🔹 Median OS: 17 months >> 60% improvement over SOC. 🔹 ~80% with liver metastases—the most challenging subset. 🔜 a randomized Phase 2b trial to advance this promising approach ✨

🧵 Recently concerns were raised about censoring in CHALLENGE trial, which randomized patients with colon cancer s/p adjuvant chemotherapy to exercise vs education nejm.org/doi/pdf/10.105…

Congratulations to Gaurav Sharma, MD Dr. Gaurav Sharma who is completing his heme-onc fellowship this month USA Mitchell Center! Paper on uncovering IO biomarkers for anal cancers - published today ESMO Open sciencedirect.com/science/articl…

Pleased to report FGFR2b expression in gastric cancer and relationship with other biomarkers ESMO Open ESMO - Eur. Oncology. The results of bemarituzumab phase 3 studies are awaited.OncoAlert OncoDaily sciencedirect.com/science/articl…

🚨 Kicking off the Pittsburgh Annual Oncology Symposium: Experts & Evidence 2025 today! A full day of cutting-edge science, thought-provoking discussions, and collaboration with some of the brightest minds in oncology. UPMC Hillman Cancer Center UPMC Physician Resources University of Pittsburgh John Rhee

Our fellows learned so much from the many amazing speakers at the 2025 Pittsburgh Annual Oncology symposium! They're already looking forward to next year! #Hematology #Oncology

🚨 STELLAR-303 makes history! First-ever Ph3 trial to show OS benefit of IO in MSS CRC 🎯 Years of grit & belief led us here 🥹 Endless thanks to Exelixis⁩ for the trust & Dr. Hecht for leading this global win with me! 🎉 ⁦UPMC Hillman Cancer Center⁩ ir.exelixis.com/news-releases/…

Anwaar Saeed UPMC Hillman Cancer Center Incredible milestone for MSS CRC! 🙌 Congratulations to Anwaar Saeed, Dr. Hecht, and the entire STELLAR-303 team on this historic achievement. A huge leap forward for IO in GI oncology. Truly inspiring work! 👏🎯 #CRC #Immunotherapy #STELLAR303 #OncologyInnovation

📢 Press release drop—interpret with appropriate caution. Exelixis reports that zanzalintinib + atezolizumab improved overall survival vs regorafenib in the Phase 3 STELLAR-303 trial for third-line MSS metastatic colorectal cancer. This isn’t the highest bar—survival in this

Congratulations Anwaar Saeed on your pioneering work! 👏🏽👏🏽👏🏽 I remember how exciting it was to hear you talk about the responses you were seeing on your CAMILLA trial. Can’t wait to 👀 the new data!

Congrats Anwaar. Huge Slay!! Practice changing!!! OncoAlert ASCO Davendra Sohal

So happy for my mentor Anwaar Saeed You rock! 🧬 🌟

Anwaar Saeed UPMC Hillman Cancer Center Congratulations, Dr. Saeed! What a journey that started from CAMILLA! Looking forward to seeing the full results ✨

Anwaar Saeed UPMC Hillman Cancer Center I already discussed this news with some of my patients… just showing what an important area of unmet need you have addressed! God bless you :)

Amazing work by Osama Younis and the team. Happy to have been a senior author on this and thanks to Anwaar Saeed for the opportunity! Through this bioinformatic approach we have shown the protective role of ENHO in PAAD. Learn more on: doi.org/10.3390/cancer…

New in Cancer: Joint series w/ Annals of Surgical Oncology on consensus guidelines for managing peritoneal surface malignancies from a multidisciplinary expert panel. 🎥 Watch an intro from Kiran Turaga and explore the full collection: acsjournals.onlinelibrary.wiley.com/doi/toc/10.100… OncoAlert Yale Medicine

For dMMR colon cancer, FOLFOX + atezolizumab per ATOMIC is now incorporated into the NCCN Guidelines. Mayo Clinic Comprehensive Cancer Center Alliance for Clinical Trials in Oncology The ASCO Post Colorectal Cancer Alliance Cure GI Cancers Fight Colorectal Cancer